DIESSE LAUNCHES THE SARS-CoV-2 “NEUTRALIZING” Ab, AN IMPORTANT TEST FOR MEASURING VACCINE EFFECTIVENESS
Siena, 29 January 2021 – DIESSE Diagnostica Senese has released a new quantitative testing kit. The SARS-CoV-2 “Neutralizing” Ab, as anticipated in December, will be available on over 2000 Chorus platforms worldwide.
The test determines the quantity of neutralizing antibodies, capable of protecting us from the SARS-CoV-2 virus, found in serum samples.
Head of Biotechnology Research at Diesse, Alessandra Brogi, hopes that “the kit can be used on a large scale to verify in a quantitative and standardised way whether or not patients who have either received the vaccine or have simply contracted COVID in the past, are in effect immune to the SARS-CoV-2 virus”.
This new test adds to the range of Diesse kits currently available. The full range of serological and antigenic kits provide for COVID-19 testing during the different stages of the disease, and result in a complete diagnostic solution.